How to Buy Acadia Pharmaceuticals Stock
Acadia Pharmaceuticals Inc
ACADIA Pharmaceuticals Inc. , a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders.
Acadia Pharmaceuticals stock last closed at $16.32, up 2.32% from the previous day, and has decreased 36.96% in one year. It has underperformed other stocks in the Biotechnology industry by 0.29 percentage points. Acadia Pharmaceuticals stock is currently +12.16% from its 52-week low of $14.55, and -49.92% from its 52-week high of $32.59.
As of Sep 13, 2024, there are 165.88M shares of ACAD outstanding. The market cap of ACAD is $2.71B. In the last 24 hours, 732,262 ACAD shares were traded.
How to Buy Acadia Pharmaceuticals Stock
Not sure how to invest in Acadia Pharmaceuticals stock? Here's how.
- Decide where to buy Acadia Pharmaceuticals stock: You need to choose an online brokerage, but don't worry - we've sifted through dozens of online stock brokerages and apps to help you choose where to buy Acadia Pharmaceuticals stock.
- Open a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
- Put funds into your investment account: Choose your payment method and add your details.
- Analyze Acadia Pharmaceuticals stock: The Acadia Pharmaceuticals ticker symbol is ACAD. Is Acadia Pharmaceuticals stock a good investment? Should you buy shares of ACAD? How do ACAD's underlying business fundamentals look? Do top analysts think Acadia Pharmaceuticals is a good buy? Why has ACAD's stock price moved recently? (Hint: Our stock market research tools can help you decide if ACAD is a good stock to buy).
- Place your ACAD buy order: Decide if you will purchase ACAD shares at the current market price or use a limit order to purchase ACAD stock at a given price.
- Get updates on your investment in ACAD: Create a watchlist to get live updates on your position in Acadia Pharmaceuticals stock.
Step 1: Decide where to buy Acadia Pharmaceuticals stock
You need a brokerage account in order to access the NASDAQ market and buy ACAD stock.
Our recommended brokerage: eToro
In our opinion, eToro is the best place to buy stocks. eToro gives you:
- You can invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
- Access to global markets: From Technology to Energy, New York to Tokyo — you can fill your portfolio with stocks from the globe's top stock exchanges.
- Social investing: eToro has a community with more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your stock purchase by signing up for an account with eToro now.
Open eToro AccountStep 2: Open a brokerage account
Now that you've picked the right brokerage, it's time to fill out some personal info so you can buy ACAD today.
How to Create a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal data to open your new trading account.
- Send your application by clicking the "Create Account" button. Get started with eToro today
Step 3: Put funds into your investment account
Now that you've opened your account on a good stock buying app, your next step is to transfer the money for your investment:
Watch this video walkthrough if you need help depositing money into your new brokerage account.
Step 4: Analyze Acadia Pharmaceuticals stock
Once you have identified the best place to buy Acadia Pharmaceuticals stock, it's critical to research their stock prior to investing, so you actually understand the risk and upside.
Acadia Pharmaceuticals stock quick numbers
Acadia Pharmaceuticals Overview
WallStreetZen was built to help everyday investors do better fundamental analysis in less time.
You can view all of the due diligence checks on ACAD's stock page.
What is the fair value of ACAD stock?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge ACAD's true value.
Using relative valuations measures:
- ACAD could be undervalued based on its P/E ratio of 90.67x, relative to Biotechnology industry P/E ratio of -245.33x
- ACAD could be undervalued based on its P/B ratio of 5.24x, relative to Biotechnology industry P/B ratio of 6.54x
- ACAD could be undervalued based on its PEG ratio of 0.94x
You can access more valuation analysis on ACAD's stock here.
ACAD Financial Summary
Positive Financial Indicators:
- ACAD earnings of $45.74M is not enough to cover its interest payments.
- There are more short-term assets than short-term liabilities on the ACAD balance sheet.
- ACAD's operating cash flow of $80.53M allows it to safely service it's debt of $47.19M.
- ACAD profit margin has gone up from -20.1% to 3.4% in the past year.
- There are more short-term assets than long-term liabilities on the ACAD balance sheet.
Negative Financial Indicators:
- Total ACAD debt is higher than 5 years ago, relative to shareholder equity.
- ACAD has a relatively high debt to equity ratio of 0.77.
Do Wall Street analysts think it's a good time to buy ACAD stock
Out of 14 Equities analysts who give forecasts on ACAD, the consensus analyst rating on ACAD is a Buy
It's important to keep in mind that analyst forecasts are not recommendations, nor are they investment advice.
Latest ACAD Analyst Ratings
Gregory Renza, a top 3% analyst from RBC Capital maintains ACAD with a buy rating and lowers their ACAD price target from $29.00 to $26.00, on Aug 7, 2024.
Jeffrey Hung, a top 12% analyst from Morgan Stanley downgrades ACAD to a hold rating and lowers their ACAD price target from $28.00 to $20.00, on Aug 7, 2024.
Keith Tapper, a top 50% analyst from BMO Capital initiates coverage on ACAD with a buy rating and announces their ACAD price target of $31.00, on Jun 27, 2024.
Tazeen Ahmad, a top 26% analyst from Bank of America maintains ACAD with a hold rating and lowers their ACAD price target from $26.00 to $22.00, on May 10, 2024.
Paul Matteis, a bottom 10% analyst from Stifel Nicolaus maintains ACAD with a hold rating and lowers their ACAD price target from $26.00 to $21.00, on May 9, 2024.
You can dig deeper into what analysts are saying on the Acadia Pharmaceuticals stock forecast page.
ACAD Momentum
Is ACAD Making Money?
Last year, ACAD revenue was $890.53M. During the past 5 year, ACAD's revenue has grown by 27.53% per year. This was slower than the Biotechnology industry average of 57.22%.
You can research ACAD's earnings and revenue performance here.
Are ACAD insiders buying or selling the stock?
Over the past year, executives and large shareholders at ACAD have sold more shares than they have bought.
Stephen Davis, CEO of ACAD, was the latest ACAD insider to sell. They sold $485,094.16 worth of ACAD shares on Aug 19, 2024.
Dig into more about who owns ACAD stock here.
Can I rely on ACAD as an income stream?
No, Acadia Pharmaceuticals doesn't provide an income stream by paying out dividends.
Get opinions from other investors
One of the biggest reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other community members have to say.
Step 5: Place your ACAD buy order
There are two main options:
- Market order: A market order is an order to buy or sell a security at the best price on the market.
Market orders are usually fine for most investors. - Limit order: A limit order allows you to buy or sell a stock at a specific price (or better).
If you want to make sure you're buying or selling at a particular dollar amount, place a limit order.
Press the Open Trade button and eToro will place your order.
If you require more info about buying stocks on eToro, watch the helpful video below:
Step 6: Get updates on your investment in ACAD
Now that you own some ACAD stock, you'll want to keep up with your company.
Make a watchlist to track the latest developments regarding your ACAD stock.
ACAD Feed
How to Buy Stock in Acadia Pharmaceuticals
To reiterate, here are the 6 steps to buy stock in Acadia Pharmaceuticals:
- Decide where to buy Acadia Pharmaceuticals stock
- Open a brokerage account
- Put funds into your investment account
- Analyze Acadia Pharmaceuticals stock
- Place your ACAD buy order
- Get updates on your investment in ACAD
If you need a online brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you would like to get notifications regarding your investment in Acadia Pharmaceuticals, click below.
Other Articles You Might Like
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.